07 Jan 2001

Levopar® 62,5 (Levopar® 62,5 mg/-125 mg/-250 mg Kapseln) - Deutschland

Updated: 07 Jan 2001

Levopar® 62,5 mg | -125 mg | -250 mg

Morbus Parkinson, symptomat. Parkinson-Syndr. (ausgenommen medikamentös induzierte Parkins.-Syndr.)

Levopar® 62,5 Description, Presentation and Dosage

Levopar® 62,5 Description

Levopar® 62,5 Drug Class Description

Kombinationen

Levopar® 62,5 Drug Description

1 Kps. enth.: Levodopa 50 mg/100 mg/200 mg, Benserazid 12,5 mg/25 mg/50 mg.

Levopar® 62,5 Generic Name

Levopar® 62,5 mg/-125 mg/-250 mg Kapseln

Levopar® 62,5 Presentation

Levopar® 62,5 Presentation

Levopar® 62,5 mg/-125 mg/-250 mg

Levopar® 62,5 Manufacturer

Hexal/Neuro Hexal

Related Learning Zones

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Levopar® 62,5 Dosage

Levopar® 62,5 Adult Dosage

Lactose 82,35 mg/164,7 mg/329,4 mg, Gelatine, Magnesiumstearat, Natriumdodecylsulfat, Siliciumdioxid, Farbstoffe E 132, E 171, zusätzl. f. Levopar 62,5 mg/-125 mg: Farbstoff E 172.

Levopar® 62,5 Elderly Dosage

1 Kps. entspr. 0,01 BE/0,01 BE/0,03 BE.

Levopar® 62,5 Precautions, Reactions and Contraindications

Levopar® 62,5 Special Precautions

Levopar® 62,5 Special Precautions

Pat

Related Drugs - Neurological Disorders

Back to top